$67.59
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. The company is headquartered in St. Louis, Missouri and currently employs 61,100 full-time employees. The company went IPO on 2001-12-13. The company provides access to quality healthcare; programs and a range of health solutions that help families and individuals get well. Its segments include Medicaid, Medicare, Commercial and Other. The Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.
Country

US

CEO

Ms. Sarah London

IPO date

2001

Employees

61,100

ISIN

US15135B1017

Key stats

Open

$67.59

Volume

4.59M

Market cap

$33.13B

Prev. close

$67.59

Impl / hst vl

-

Open interest

$0.00

$67.59

Day’s Range

$67.59

$31.63

52W Range

$69.29

Valuation

44
Valuation score
Fairly Valued
P/E
-
P/S
0.17
P/B
1.54
Current ratio
1.12
Debt / Equity
-0.23
ROE
-28.72%
Gross margin
11.13%
Income growth
-239.96%
FCF growth
4,748.84

Analysts estimates

Consensus rating
Hold

The average rating from top 15 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$63.87
The top 22 analysts forecasts that 12-month price may decrease by 5.50%, with a low of $40.40 and a high of $84.00
$40.40
Low
$63.87
Avg
$84.00
High
Current price

Earnings

Q1 ‘26 revenue
$49.94B
Q1 ‘26 net income
$1.54B
Revenue
Net income
Previous EPS
$3.37
Estimate EPS
$1.07
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply